✦ LIBER ✦

Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study

✍ Scribed by Serafín Morales; Antonio Lorenzo; Manuel Ramos; Pedro Ballesteros; Miguel Méndez; Concepción Almanza; Javier Castellanos; JoséAndrés Moreno-Nogueira; Joaquín Casal; José Lizón; Amparo Oltra; Adolfo Frau; Ignacio Machengs; Antonio Galán; Joaquín Belón; Cristina Llorca

Publisher: Springer
Year: 2003
Tongue: English
Weight: 196 KB
Volume: 53
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-003-0690-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide/liposomal daunorubicin is a w

Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma : Results of a Phase II study

✍ Jan M. Siehl; Eckhard Thiel; Alexander Schmittel; Gero Hütter; Peter M. Deckert; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

Multicenter phase II study of trastuzuma

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB